Drugs Ask - QuikReader

Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.

Business - CNBC - October 30

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - October 30

This retirement expert saved her mom $1,200 on Medicare drugs — and she’s got advice for you, too

It took many frustrating years for Marcia Mantell to convince her mom to let her help.

Business - MarketWatch - November 2

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

Business - CNBC - October 31

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.

Business - CNBC - October 31

EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...

World - ABC News - October 31

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug